REGISTERED
on 24 Sep 2024
Last Applicant/ Owned by
SE-752 37 Uppsala
SE
Serial Number
79357279 filed on 20th Sep 2022
Registration Number
7510099 registered on 24th Sep 2024
Correspondent Address
Jolly-Johanna L. Northrop
Jolly-Johanna L. Northrop Holland & Hart LLP
Attn: Trademark Docketing
Denver, CO 80201
United States
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
PHARMETHEUS
Medical research; scientific research; providing medical and scientific research information; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals; research on the subject of pharmaceuticals and interactions between pharmaceuticals and patients; services for assessing the efficacy of pharmaceu Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; medical analysis services relating to the treatment of patients; medical analysis services for diagnostic and treatment purposes; pharmaceutical services, namely, consultancy and information services relating to pharmaceutical products; pharmaceutical advice; pharmaceutical analysis services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical research; scientific research; providing medical and scientific research information; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals; research on the subject of pharmaceuticals and interactions between pharmaceuticals and patients; services for assessing the efficacy of pharmaceuticals, namely, pharmaceutical research services relating to the assessment of the efficacy of pharmaceuticals; software as a service (SAAS) services featuring software for assessing the efficacy of pharmaceuticals; research in the field of pharmacology, physiology and disease; research in the field of pharmacokinetics and pharmacodynamics; consultancy relating to research in the field of pharmacokinetics and pharmacodynamics; consultancy relating to pharmaceutical research and development; consultancy in the field of pharmaceutical research; pharmaceutical research and development; scientific analytical services in the field of pharmacokinetics and pharmacodynamics; consultancy relating to pharmacological analysis and research; design of mathematical models for the analysis of interactions between pharmaceuticals and patients; design of computer-simulated mathematical models; computer software development; software design and development; design and development of software in the field of mobile applications
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable computer software in the fields of pharmaceuticals, biotechnology, healthcare, and life sciences for pharmaceutical research and development; downloadable computer software for providing medical and scientific research information in the field of pharmaceuticals and for analyzing and assessing the efficacy of pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79357279
Mark Type
No Service Mark
Attorney Docket Number
No 118683.0002
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 24th Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
| 27th Jul 2024 | NEW REPRESENTATIVE AT IB RECEIVED |
| 09th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 19th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 30th May 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 30th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 30th May 2024 | EXAMINER'S AMENDMENT ENTERED |
| 30th May 2024 | EXAMINERS AMENDMENT E-MAILED |